Welcome to Aetos Life Care. Looking for a reliable pharmaceutical manufacturer?

Gliclazide Tablets BP 80mg

Gliclazide is a second-generation sulfonylurea used for the treatment of Type 2 Diabetes Mellitus. It stimulates insulin secretion from pancreatic beta cells, improving glucose control and preventing diabetes-related complications.

Category:
QUICK INQUIRY NOW

Description

Mechanism of Action:

✔ Stimulates insulin secretion, leading to lower blood sugar levels.
✔ Improves peripheral glucose utilization.
✔ Reduces hepatic glucose production.

Indications:

✔ Type 2 Diabetes Mellitus
✔ Glycemic control in non-insulin-dependent diabetes

Key Benefits:

✅ Effective blood sugar reduction
✅ Helps prevent diabetes-related complications
✅ Suitable for long-term diabetes management

Dosage & Administration:

  • Recommended Dosage: 80 mg once or twice daily or as prescribed.
  • Route of Administration: Oral
  • Food Intake: Best taken with meals to avoid hypoglycemia.

Precautions & Warnings:

  • Not suitable for Type 1 diabetes or diabetic ketoacidosis.
  • Use cautiously in patients with renal or hepatic impairment.
  • Monitor blood sugar levels regularly to avoid hypoglycemia.

Possible Side Effects:

  • Hypoglycemia (low blood sugar)
  • Nausea, headache, or dizziness
  • Weight gain in some patients

Storage & Packaging:

  • Store below 30°C, in a dry, cool place.
  • Available in blister packs and bulk packaging as per client needs.

Manufacturing & Regulatory Compliance:

Manufactured by Aetos Life Care in WHO-GMP certified facilities, ensuring compliance with EU-GMP standards.

Global Export & Supply:

Aetos Life Care exports Gliclazide Tablets BP 80 mg to Latin America, Africa, Asia, Europe, and CIS countries, providing cost-effective diabetes treatment worldwide.

Leading Manufacturer and Exporter of Pharmaceuticals Across Continents

Aetos Life Care is a trusted manufacturer and exporter of high-quality generic and specialty medicines, serving over 40 countries across Latin America, Africa, Asia, Europe, and the CIS region. We have a strong presence in key markets, including Iraq, Jordan, Saudi Arabia, UAE, Ukraine, Kazakhstan, Venezuela, Ecuador, and more. Backed by 15 WHO-GMP accredited facilities designed to meet EU-GMP standards, we ensure the highest quality, safety, and compliance in every product we deliver.

Iraq, Jordan, Riyadh (Saudi Arabia), Dubai (UAE)

Ukraine, Kazakhstan, Turkmenistan, Tajikistan

Venezuela, Ecuador, Peru, Paraguay, Panama, Costa Rica, El Salvador

Cameroon, South Sudan, Angola

Myanmar